Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Intrapulmonary administration of polynucleotide toll-like receptor 9 agonists for treating cancer of the lung

Intrapulmonary administration of polynucleotide toll-like receptor 9 agonists for treating cancer of the lung

US Patent 9993495 · Granted Jun 12, 2018

Estimated economic value: $22,119,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Toll-like receptor antagonist compounds and methods of use2025
Immunogenic composition against severe acute respiratory syndrome coronavirus 2 2025
CBL inhibitors and compositions for use in adoptive cell therapy2024
Combination therapies with Cbl-b inhibitor compounds2024
Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof2024
Combination of a PD-1 antagonist and CpG-C type oligonucleotide for treating can2024
Combination of a PD-1 antagonist and CpG-C type oligonucleotide for treating can2024
Toll-like receptor antagonist compounds and methods of use2023
Toll-like receptor antagonist compounds and methods of use2022
Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof2021
Combination of a PD-1 antagonist and CPG-C type oligonucleotide for treating can2020
Combination of a PD-1 antagonist and CPG-C type oligonucleotide for treating can2020